Addex Therapeutics Long Term Debt

As of the most recent data (March 2026), ADXN shows a long-term debt of $25K. That compares with $33K in the prior-year period — down 23.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ADXN's long-term debt is now $25K (was $33K) — a 23.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Addex Therapeutics is outperforming or lagging.

Tracking ADXN's long-term debt over time shows whether Addex Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $25K That compares with $33K in the prior-year period — down 23.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Addex Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $25K) with ownership activity and broader fundamentals.

Addex Therapeutics's long-term debt is $25K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.